Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)

NCT05089084 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Chylomicronemia

Interventions

DRUG: Plozasiran
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals